With regard to the fact that as far as we know in the literature there is no published data regarding associations of PDCD1 and PD-L1 polymorphisms with ccRCC risk and outcomes, we believe that our research will broaden current knowledge of the genetic basis of this type of cancer. The gene discussed is PDCD1; the disease is nonpapillary renal cell carcinoma.